Medtronic, Edwards TAVI rivalry heats up with dual CoreValve boosts
This article was originally published in Clinica
Executive Summary
Medtronic is closing in on Edwards Lifesciences, its arch rival in the transcatheter aortic valve repair implantation market, after the CoreValve system passed significant regulatory milestones in Japan and the US.